{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:38:32Z","timestamp":1789843112274,"version":"4.0.1"},"reference-count":83,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2010,6,30]],"date-time":"2010-06-30T00:00:00Z","timestamp":1277856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Clin Biochem"],"published-print":{"date-parts":[[2010,7]]},"abstract":"<jats:p>Hyperprolactinaemia is a common adverse event reported in association with treatments used in schizophrenia and bipolar disorder. Recent data are suggestive that hyperprolactinaemia may have a range of significant short-and long-term clinical consequences. The objective of this review is to examine the causes, frequency and clinical consequences of hyperprolactinaemia in the severely mentally ill (SMI) with a focus on patients taking antipsychotic medications. A Medline search was carried out to identify relevant publications. Reference lists from previous review articles were also examined to search for additional data. Hyperprolactinaemia may be one of the most common adverse events associated with some antipsychotic medications. Precise rates with individual drugs had however until recently been poorly categorized. The relationship between hyperprolactinaemia and adverse outcomes in the SMI population appears similar to that in the general population. Adverse outcomes (such as sexual dysfunction) can occur acutely and in the longer term (bone fractures and possibly breast cancer), but the precise link between degree and length of hyperprolactinaemia and adverse outcome remains to be established. In conclusion, hyperprolactinaemia is a common treatment-emergent adverse event of some antipsychotic medications and may have clinical consequences. Physicians must balance the benefits and risks of treatment when determining appropriate therapy for individual patients.<\/jats:p>","DOI":"10.1258\/acb.2010.010025","type":"journal-article","created":{"date-parts":[[2010,6,30]],"date-time":"2010-06-30T17:52:57Z","timestamp":1277920377000},"page":"292-300","source":"Crossref","is-referenced-by-count":41,"title":["A review of hyperprolactinaemia and severe mental illness: Are there implications for clinical biochemistry?"],"prefix":"10.1177","volume":"47","author":[{"given":"Chris J","family":"Bushe","sequence":"first","affiliation":[{"name":"Eli Lilly and Company Ltd, Basingstoke"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Bradley","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company Ltd, Basingstoke"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Pendlebury","sequence":"additional","affiliation":[{"name":"Ramsgate House, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2010,6,30]]},"reference":[{"key":"bibr-ACB-10-025C1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200464200-00003"},{"key":"bibr-ACB-10-025C2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881107088435"},{"key":"bibr-ACB-10-025C3","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.106.023671"},{"key":"bibr-ACB-10-025C4","doi-asserted-by":"publisher","DOI":"10.1177\/0269881107082624"},{"key":"bibr-ACB-10-025C5","doi-asserted-by":"publisher","DOI":"10.1592\/phco.29.1.64"},{"key":"bibr-ACB-10-025C6","doi-asserted-by":"publisher","DOI":"10.1177\/0269216307087148"},{"key":"bibr-ACB-10-025C7","doi-asserted-by":"publisher","DOI":"10.1177\/0269881107087346"},{"key":"bibr-ACB-10-025C8","doi-asserted-by":"publisher","DOI":"10.1177\/0269881107075509"},{"key":"bibr-ACB-10-025C9","doi-asserted-by":"publisher","DOI":"10.1152\/ajplegacy.1933.105.1.191"},{"key":"bibr-ACB-10-025C10","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.2000.80.4.1523"},{"key":"bibr-ACB-10-025C11","doi-asserted-by":"publisher","DOI":"10.1177\/0269216307087147"},{"key":"bibr-ACB-10-025C12","doi-asserted-by":"publisher","DOI":"10.1210\/endo-128-4-1887"},{"key":"bibr-ACB-10-025C13","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-15-5-627"},{"key":"bibr-ACB-10-025C14","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)69558-X"},{"key":"bibr-ACB-10-025C15","doi-asserted-by":"publisher","DOI":"10.1177\/0269881107087951"},{"key":"bibr-ACB-10-025C16","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/46.4.551"},{"key":"bibr-ACB-10-025C17","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.22.6.0451"},{"key":"bibr-ACB-10-025C18","doi-asserted-by":"publisher","DOI":"10.1177\/000456328602300603"},{"key":"bibr-ACB-10-025C19","doi-asserted-by":"publisher","DOI":"10.1177\/0269881107078281"},{"key":"bibr-ACB-10-025C20","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.184.6.503"},{"key":"bibr-ACB-10-025C21","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31818ba5d8"},{"key":"bibr-ACB-10-025C22","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2007.164.7.1050"},{"key":"bibr-ACB-10-025C23","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1998.00343.x"},{"key":"bibr-ACB-10-025C24","first-page":"65","volume":"56","author":"Greer ME","year":"1980","journal-title":"Obstet Gynecol"},{"key":"bibr-ACB-10-025C25","doi-asserted-by":"publisher","DOI":"10.1385\/ENDO:20:1-2:75"},{"key":"bibr-ACB-10-025C26","first-page":"3053","volume":"85","author":"Pinzone JJ","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"bibr-ACB-10-025C27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2006.02562.x"},{"key":"bibr-ACB-10-025C28","first-page":"575","volume":"169","author":"Serri O","year":"2003","journal-title":"Can Med Assoc J"},{"key":"bibr-ACB-10-025C29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2007.00520.x"},{"key":"bibr-ACB-10-025C30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0806994"},{"key":"bibr-ACB-10-025C31","doi-asserted-by":"publisher","DOI":"10.1007\/BF00421361"},{"key":"bibr-ACB-10-025C32","doi-asserted-by":"publisher","DOI":"10.1007\/BF02245606"},{"key":"bibr-ACB-10-025C33","doi-asserted-by":"publisher","DOI":"10.1177\/070674370204700106"},{"key":"bibr-ACB-10-025C34","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.1.133"},{"key":"bibr-ACB-10-025C35","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.035303"},{"key":"bibr-ACB-10-025C36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1981.tb00666.x"},{"key":"bibr-ACB-10-025C37","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.5.1010"},{"key":"bibr-ACB-10-025C38","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGENETICS.109.853572"},{"key":"bibr-ACB-10-025C39","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2007.01.013"},{"key":"bibr-ACB-10-025C40","doi-asserted-by":"publisher","DOI":"10.1177\/0269881107088439"},{"key":"bibr-ACB-10-025C41","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v68n0302"},{"key":"bibr-ACB-10-025C42","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000150223.31007.e0"},{"key":"bibr-ACB-10-025C43","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2004.05.010"},{"key":"bibr-ACB-10-025C44","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2004.06.013"},{"key":"bibr-ACB-10-025C45","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2008.02.008"},{"key":"bibr-ACB-10-025C46","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2007.06071075"},{"key":"bibr-ACB-10-025C47","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2005.12.006"},{"key":"bibr-ACB-10-025C48","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v69n0907"},{"key":"bibr-ACB-10-025C49","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2009.07.012"},{"key":"bibr-ACB-10-025C50","volume-title":"Globocan 2002. Cancer Incidence, Mortality and Prevalence Worldwide, Version 2.0: IARC CancerBase no.5","author":"Ferlay J","year":"2004"},{"key":"bibr-ACB-10-025C51","unstructured":"Office for National Statistics. Cancer Statistics registrations: Registrations of cancer diagnosed in 2004, England. Series MB1 no.35. 2007, National Statistics: London"},{"key":"bibr-ACB-10-025C52","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2008.01163.x"},{"key":"bibr-ACB-10-025C53","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.64.12.1368"},{"key":"bibr-ACB-10-025C54","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-008-8463-x"},{"key":"bibr-ACB-10-025C55","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.07.6356"},{"key":"bibr-ACB-10-025C56","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2006.01.032"},{"key":"bibr-ACB-10-025C57","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-3369"},{"key":"bibr-ACB-10-025C58","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.59.12.1147"},{"key":"bibr-ACB-10-025C59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000201"},{"key":"bibr-ACB-10-025C60","doi-asserted-by":"publisher","DOI":"10.1592\/phco.26.6.748"},{"key":"bibr-ACB-10-025C61","doi-asserted-by":"publisher","DOI":"10.1177\/0269881108091252"},{"key":"bibr-ACB-10-025C62","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2008.04.014"},{"key":"bibr-ACB-10-025C63","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200204000-00002"},{"key":"bibr-ACB-10-025C64","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n0704"},{"key":"bibr-ACB-10-025C65","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-1870"},{"key":"bibr-ACB-10-025C66","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2008.11.003"},{"key":"bibr-ACB-10-025C67","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051688"},{"key":"bibr-ACB-10-025C68","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2006.09.012"},{"key":"bibr-ACB-10-025C69","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199902000-00011"},{"key":"bibr-ACB-10-025C70","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2007.03.003"},{"key":"bibr-ACB-10-025C71","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.5.947"},{"key":"bibr-ACB-10-025C72","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000186738.84276.9f"},{"key":"bibr-ACB-10-025C73","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(97)00036-4"},{"key":"bibr-ACB-10-025C74","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2004.07.003"},{"key":"bibr-ACB-10-025C75","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2007.03.002"},{"key":"bibr-ACB-10-025C76","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v68n0206"},{"key":"bibr-ACB-10-025C77","unstructured":"BusheC, SniadeckiJ, BradleyAJ, HoffmanVP. Comparison of metabolic and prolactin variables from a six-month randomised trial of olanzapine and quetiapine in schizophrenia. J Psychopharmacol, 2008 (in press). Epub 17 Nov 2008"},{"key":"bibr-ACB-10-025C78","unstructured":"National Institute for Health and Clinical Excellence (NICE). Bipolar disorder. The management of bipolar disorder in adults, children and adolescents, in primary and secondary care. NICE clinical guideline 38, 2006 (cited 14 March 2009) See www.nice.org.uk\/CG038"},{"key":"bibr-ACB-10-025C79","doi-asserted-by":"publisher","DOI":"10.1201\/b21605"},{"key":"bibr-ACB-10-025C80","doi-asserted-by":"publisher","DOI":"10.1080\/15622970500483177"},{"key":"bibr-ACB-10-025C81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1176\/appi.ajp.161.1.1","volume":"161","author":"Lehman AF","year":"2004","journal-title":"Am J Psych"},{"key":"bibr-ACB-10-025C82","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.8.1334"},{"key":"bibr-ACB-10-025C83","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1998.00569.x"}],"container-title":["Annals of Clinical Biochemistry: International Journal of Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1258\/acb.2010.010025","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1258\/acb.2010.010025","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1258\/acb.2010.010025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:55:59Z","timestamp":1777377359000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1258\/acb.2010.010025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,30]]},"references-count":83,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["10.1258\/acb.2010.010025"],"URL":"https:\/\/doi.org\/10.1258\/acb.2010.010025","relation":{},"ISSN":["0004-5632","1758-1001"],"issn-type":[{"value":"0004-5632","type":"print"},{"value":"1758-1001","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,30]]}}}